Photo from wikipedia
MEFIB (the combination of magnetic resonance elastography [MRE] ≥ 3.3 kPa and fibrosis‐4 (FIB‐4) ≥ 1.6) is useful for detecting patients with significant fibrosis (fibrosis stage ≥ 2) having nonalcoholic… Click to show full abstract
MEFIB (the combination of magnetic resonance elastography [MRE] ≥ 3.3 kPa and fibrosis‐4 (FIB‐4) ≥ 1.6) is useful for detecting patients with significant fibrosis (fibrosis stage ≥ 2) having nonalcoholic fatty liver disease (NAFLD). However, age‐dependent thresholds of FIB‐4 have been proposed, and it remains unclear whether MEFIB could be applied with the same FIB‐4 threshold in a different cohort. Therefore, in this study, we examined the best threshold of FIB‐4 and validated the utility of MEFIB.
Keywords:
magnetic resonance;
nonalcoholic fatty;
fatty liver;
resonance elastography;
significant fibrosis;
fibrosis
Journal Title: Journal of Gastroenterology and Hepatology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Gastroenterology and Hepatology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!